Profile data is unavailable for this security.
About the company
Crossject SA is a France-based company that designs and develops medical injection systems. The Company specializes in needle-free, pre-filled, single-use injection systems for intradermal, subcutaneous, and intramuscular applications for pharmaceutical companies. Is also has a pipeline and three drugs in the preclinical or clinical phase of research. The Company's products, which are based on well-known injectable drugs (chemicals and biologics), are designed to enhance patients' safety, compliance, and comfort. The Company has industrial partnerships with Hirtenberger and Recipharm. It provides Zeneo, a prefilled and single-use device that can be used for intradermal, subcutaneous and intramuscular injections.
- Revenue in EUR (TTM)0.00
- Net income in EUR-11.26m
- Incorporated2001
- Employees103.00
- LocationCrossject SAParc Mazen-Sully6 Rue Pauline KergomardDIJON 21000FranceFRA
- Phone+33 380549850
- Fax+33 148046723
- Websitehttps://www.crossject.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mauna Kea Technologies SA | 7.48m | -10.39m | 24.17m | 61.00 | -- | -- | -- | 3.23 | -0.1407 | -0.1407 | 0.1015 | -0.3689 | 0.4854 | 1.19 | 4.59 | 115,015.40 | -68.47 | -47.72 | -- | -149.19 | 43.20 | 18.06 | -141.06 | -129.39 | 0.1177 | -- | 9.54 | -- | -26.96 | 0.5957 | -179.15 | -- | -31.06 | -- |
| Ikonisys SA | 617.19k | -2.70m | 25.35m | 10.00 | -- | 1.06 | -- | 41.07 | -0.1334 | -0.1334 | 0.0609 | 1.51 | 0.0252 | 0.8103 | 3.40 | 61,719.00 | -11.01 | -- | -14.76 | -- | 0.943 | -- | -437.39 | -- | 0.0691 | -30.68 | 0.1686 | -- | -27.28 | -- | 7.38 | -- | -- | -- |
| Implanet SA | 11.10m | -4.81m | 32.93m | 44.00 | -- | -- | -- | 2.97 | -0.038 | -0.038 | 0.0876 | -0.0108 | 0.7432 | 0.8618 | 5.06 | 253,379.00 | -32.23 | -37.85 | -176.46 | -98.02 | 52.11 | 58.59 | -43.36 | -68.07 | 0.2485 | -- | 1.29 | -- | 26.31 | 4.89 | 21.87 | -- | 25.84 | -- |
| Diagnostic Medical Systems SA | 46.77m | -1.67m | 35.45m | 140.00 | -- | 2.21 | 39.08 | 0.7579 | -0.069 | -0.069 | 2.05 | 0.6006 | 0.876 | 1.84 | 4.52 | 324,798.60 | -2.86 | -11.47 | -5.81 | -20.52 | 39.79 | 38.72 | -3.27 | -14.95 | 0.6154 | -0.5203 | 0.5811 | -- | 9.29 | 8.24 | 70.50 | -- | -- | -- |
| Theraclion SA | 1.90m | -5.25m | 36.08m | 33.00 | -- | -- | -- | 18.96 | -0.1127 | -0.1127 | 0.0408 | -0.0548 | 0.1479 | 0.3304 | 8.74 | 59,455.31 | -40.84 | -33.44 | -55.80 | -47.33 | 54.01 | 66.95 | -276.15 | -360.91 | 1.79 | -67.33 | 2.50 | -- | -54.44 | -21.49 | -56.66 | -- | -4.97 | -- |
| AbL Diagnostics SA | 5.45m | 463.37k | 57.37m | 20.00 | 123.70 | 8.26 | 47.63 | 10.53 | 0.0288 | 0.0288 | 0.3383 | 0.4308 | 0.4416 | -- | 1.60 | 286,763.20 | 3.76 | 3.59 | 5.34 | 5.29 | -- | -- | 8.50 | 8.20 | 2.91 | -- | 0.2788 | -- | -5.03 | -- | 424.60 | -- | -- | -- |
| Crossject SA | 0.00 | -11.26m | 110.41m | 103.00 | -- | 29.13 | -- | -- | -0.2262 | -0.2262 | 0.00 | 0.0721 | 0.00 | -0.1209 | -- | 0.00 | -34.94 | -34.43 | -85.62 | -62.51 | -- | 1,027.62 | -- | -2,647.69 | 0.589 | -9.88 | 0.8473 | -- | -100.00 | -- | -48.12 | -- | -4.33 | -- |
| Guerbet SA | 809.67m | 7.74m | 175.96m | 2.91k | 34.25 | 0.4664 | 2.50 | 0.2173 | 0.4064 | 0.4064 | 64.25 | 29.85 | 0.7865 | 0.546 | 4.90 | 278,715.70 | 0.4619 | 0.92 | 0.6055 | 1.20 | 78.03 | 76.51 | 0.5873 | 1.19 | 1.03 | 1.46 | 0.5172 | 64.79 | 7.05 | 0.5853 | -32.61 | -15.50 | -0.8569 | -- |
| Median Technologies SA | 23.31m | -21.99m | 200.48m | 211.00 | -- | -- | -- | 8.60 | -1.16 | -1.16 | 1.23 | -2.08 | 0.8894 | -12.98 | 3.92 | 96,717.84 | -83.91 | -60.70 | -- | -232.35 | 102.73 | 102.32 | -94.35 | -97.73 | 0.3543 | -26.56 | -- | -- | 3.25 | 20.72 | -9.83 | -- | 43.77 | -- |
| Affluent Medical SAS | 4.12m | -14.74m | 213.28m | 76.00 | -- | 6.71 | -- | 51.79 | -0.3759 | -0.3759 | 0.1051 | 0.5365 | 0.0709 | -- | 0.9541 | 59,681.16 | -25.40 | -23.76 | -32.61 | -27.59 | 1.34 | -226.93 | -358.01 | -1,815.40 | -- | -924.30 | 0.5030 | -- | -- | -- | 5.84 | -- | -- | -- |
| Lumibird SA | 215.95m | 10.73m | 523.48m | 1.07k | 48.80 | 2.62 | 17.20 | 2.42 | 0.4775 | 0.4775 | 9.61 | 8.90 | 0.5077 | 0.9593 | 4.42 | 202,198.50 | 2.52 | 2.51 | 3.11 | 3.17 | 63.89 | 61.89 | 4.97 | 4.90 | 1.64 | 3.16 | 0.4583 | 0.00 | 1.75 | 13.34 | -20.08 | -8.38 | 15.27 | -- |
Data as of Feb 13 2026. Currency figures normalised to Crossject SA's reporting currency: Euro EUR
1.42%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| OFI Invest Asset Management SAas of 29 Jan 2026 | 580.00k | 1.11% |
| Montpensier Arbevel SASas of 30 Dec 2022 | 164.26k | 0.31% |
| Optigestion SAas of 29 Dec 2023 | 0.00 | 0.00% |
Data from 29 Dec 2023 - 01 Feb 2026Source: FactSet Research Systems Inc.
